/Companies

Imago

acquired by Merck

16 known investors

Find your way into Imago

Sign up to see every warm intro you have to Imago

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Imago team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments. It has operated for over 130 years and serves patients and healthcare needs globally.

Investors · 16

Also in the syndicate · 4

Farallon Capital ManagementleadKindgon Capital ManagementPharmaron InvestmentsSurveyor Capital

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Imago do?
A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments. It has operated for over 130 years and serves patients and healthcare needs globally.
Who are Imago's investors?
Imago's investors include Frazier Life Sciences, Highlight Capital, MRL Ventures Fund, Xeraya Capital, Amgen Ventures, BlackRock, Blackstone Life Sciences, Clarus Ventures and 4 more.
Who acquired Imago?
Imago was acquired by Merck.